Public procurement notice: Contract Notice
Published: 2020-03-12
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 14878505 GBP
Submission deadline: 2020-04-14
Award criteria: The most economic tender

Technical requirements: All entities constituted pursuant to the National Health Service (Scotland) Act 1978 and any integrated joint boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Supply of octreotide vials in a secondary care setting to NHS Scotland. The authority intends to award this lot as an unranked multi-supplier framework to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.
This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978 and any integrated joint boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Supply of octreotide vials in a homecare setting to NHS Scotland. The authority intends to award this Lot as an unranked multi-supplier framework to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.
This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978 and any integrated joint boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Supply of dasatinib tablets to NHS Scotland. The authority intends to award this lot as a ranked multi-supplier framework to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.
This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978 and any integrated joint boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Supply of azacitidine vials and erlotinib tablets to NHS Scotland. The authority intends to award this lot as a single supplier framework per line. Full details of goods and volumes can be found within the ITT documents.
This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods at the date of submission of the tender;
(b) potential framework participants and any subcontractor(s) must possess valid certification of BS EN ISO 9001 or equivalent;

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 14878505